Document Page: First | Prev | Next | All | Image | This Release | Search
File: aabhd_02.txtPRIORITY UNCLASSIFIED BASE COMMUNICATIONS CENTER 390 COSQ/DONA PAGE 02 OF 02 RHDIAAA 4956 22/0748Z THE DIAGNOSIS IS NOT CLEAR, CONSIDER UP TO A 3 DAY TRIAL OF MANAGEMENT AT THE ATH SINCE IT IS NOT RECOMMENDED THAT COMBAT STRESS PATIENTS BE EVACUATED REARWARD. B. NOTE: UPON DISCHARGE, APPROPRIATE DUTY RESTRICTIONS SHOULD BE ISSUED. MIOSIS AND ACCOMPANYING VISUAL DISTURBANCES MAY PERSIST FOR WEEKS, EVEN WITH MILD EXPOSURES. ATROPINE, EVEN AFTER 2MG, WILL AGGRAVATE THE TENDENCY FOR HEAT RELATED ILLINESS. C. NOTE: MINIMAL SYMPTOMS AS DEFINED IN GUIDELINES FOR MANAGEMENT OF NERVE AGENT CASUALTIES AT USCENTAF 2E FACILITIES ARE NASAL CONGESTION, EYE PAIN, BLURRED OR DIM VISION, RETROBULBAR HEADACHE, MILD CHEST TIGHTNESS, AND NAUSEA. B. VESICANT AGENT CASUALTIES (E.G., MUSTARD) (1) EYE EXPOSURE A. SEVERE - CORNEAL OPACIFICATION WITH ULCERTION AND/OR VASCULARIZATION WITH OR WITHOUT ISCHEMIC NECROSIS OF CONJUNCTIVAE. EXPECT RETURN TO DUTY-SEVERAL MONTHS IF EVER. B. MODERATE - CORNEAL ERDSION, SUPERFICIAL CORNEAL SCARRING AND/'OR VASCULARIZATION, IRITIS. EXPECT RETURN TO DUTY 2 PLUS MONTHS. C. MILD - ORANGE - PEEL ROUGHENING OF CORNEA, BLEPHAROSPASM, LID EDEMA, MARKED CONJUNCTIVITIS EXPECT RETURN TO DUTY 2-5 WEEKS. D. CONJUNCTIVITIS ONLY. EXPECT RETURN TO DUTY 1-2 WEEKS. (2) SKIN EXPOSURE A. SEVERE - GREATER THAN 10 PERCENT BODY SURFACE AREA OR INVOLVEMENT OF FACE, NECK, AXILLA, OR GROIN MORE SEVERE THAN ERYTHEMA. EXPECT TO EVACUATE OUT OF THEATER. B. MODERATE - MULTIPLE PINPOINT VESICLES REGARDLESS OF BODY SURFACE AREA INVOLVED. EXPECT RETURN TO DUTY IN 1-2 WEEKS. C. MILD - ERYTHEMA ONLY. EXPECT RETURN TO DUTY AS FOR COMPARABLE SUNBURN (3) RESPIRATORY EXPOSURE A. AIRWAY INJURY REQUIRING ADMISSION. EXPECT TO EVACUATE OUT OF THEATER B. MILD - HOARSENESS./SORE THROAT ONLY. EXPECT RETURN TO DUTY IN 12 HOURS 2 . REQUEST USCENTAF FWD/SG REVIEW AND RETRANSMIT THESE GUTDELINES AS APPROPRIATE. [(b)(2)] UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search